MULTIPLE CLINICAL APPLICATIONS
Measuring the neutralizing antibodies potency are expected to
build a defense against SARS-CoV-2 spreading, complementing
vaccines and nonpharmaceutical interventions.
For vaccine efficacy monitoring
Understanding the human body’s immune response to
SARS-CoV-2, the virus that causes COVID-19, is key to developing
effective treatments and long-lasting vaccines.
For treatment options guiding
Potent nAbs that were more effective at neutralizing the virus have
better clinical outcomes. Early administration of nAbs is vital to
identify patient of severity risk as an aid to treatment.
FEATURES
Cost-effective, reproducible and time-saving
Only 10 mins for results.Suitable for large scale testing to
evaluate herd immunity in community
High sensitivity and specificity
Up to 100% positive agreement with gold standard VNT